Baptist Health, a faith-based mission-driven system in north-east Florida, has installed VuCOMP’s advanced breast cancer detection systems, the M-Vu Breast Density and M-Vu Computer Aided Detection (CAD), throughout its network of imaging centres in Jacksonville, Florida.
All Baptist Health hospitals, along with Baptist Home Health Care, have achieved Magnet status for excellence in patient care.
Baptist Breast Health Services locations offer advanced screening technologies, including GE digital mammography, and are said to be the first in the region to use both VuCOMP breast cancer detection technologies.
M-Vu Breast Density is a tool for radiologists that provides assessment of breast density from a digital mammogram.
The M-Vu Breast Density utilises mathematical algorithms to evaluate the appearance of structures and textures in the breast to differentiate between fatty and dense regions.
The algorithms then calculate a percentage of breast area that is dense and convert it to one of four density categories corresponding to the BI-RADS standard. This exclusive approach using appearance-based analysis provides useful adjunctive information.
Baptist Health breast imaging medical director Dr Christine AJ Granfield said that the health system has seen firsthand the difference that early detection can make for women with breast cancer.
"We find the M-Vu computer-generated Breast Density values very beneficial and consistent. Also, the M-Vu CAD identifies areas of suspicion more accurately than our previous system, and is therefore more usable and effective," Dr Granfield added.
The M-Vu CAD system received a supplementary approval from the US Food and Drug Administration (FDA) for digital mammography in October 2012.
According to VuCOMP, recent FDA guidelines have significantly raised the bar for CAD performance and now recommend comprehensive studies proving that radiologists are more effective when they use CAD technology.
The VuCOMP system is reportedly the first FDA-approved mammography CAD product that meets these recommendations. M-Vu Breast Density received FDA approval in December 2013.
VuCOMP CEO Jeff Wehnes said that Dr Granfield and her team at Baptist Health are taking a progressive, industry-leading approach to the early detection of breast cancer.
"We are pleased to partner with them in providing the benefits of our M-Vu CAD and M-Vu Breast Density to the more than 65,000 women they evaluate annually, and look forward to continuing to provide them with the most advanced breast imaging tools available," Wehnes added.
Baptist Health includes the area’s only dedicated heart hospital; a cancer centre; orthopaedic institute; women’s services; neurosciences, including neurosurgery and two Joint Commission-certified stroke centres; a Bariatric Center of Excellence; a full range of psychology and psychiatry services; outpatient facilities; urgent care services; and primary and speciality care physicians’ offices throughout north-east Florida.
Baptist Health also recently opened the J. Wayne and Delores Barr Weaver Tower and Baptist Clay Medical Campus.
Image: Baptist Medical Center South in Jacksonville, Florida. Photo courtesy of Mgreason.